Clinical Trial Update: Evaluation of De-escalated Adjuvant Radiation Therapy for Human Papillomavirus (HPV)-Associated Oropharynx Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating de-escalated adjuvant radiation therapy for HPV-associated oropharyngeal cancer has completed and posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hpv-associated Oropharyngeal Cancer
• Oropharyngeal Cancer

Snippet

Sponsor: Mayo Clinic | Conditions: Oropharynx Cancer | Phase 3 | Status: COMPLETED | Results posted: 2024-04-08